Who are Debio 4126's main competitors?

Direct comparators (same drug class / molecular target / therapeutic area): Debio 4326.

How often does this brief refresh?

Every 30 minutes from primary sources (FDA, EMA, MHRA, PMDA, ClinicalTrials.gov, USPTO). Subscribe to the RSS feed below for push alerts.

How do I get this as a recurring report?

Subscribe to /feed/ci/debio-4126.xml in any RSS reader (Feedly, Inoreader, NewsBlur). Every regulatory action, trial readout, or patent event lands in your feed automatically.

Last reviewed 2026-05-15 · How we verify

Debio 4126 — Competitive Intelligence Brief

Debio 4126 (Debio 4126) competitive landscape: 1 comparator, recent regulatory actions, upcoming PDUFA, patent timeline. Class: Mitochondrial complex I inhibitor. Area: Oncology.

phase 3 Mitochondrial complex I inhibitor Mitochondrial complex I (NADH dehydrogenase) Oncology Small molecule Live · refreshed every 30 min

Target snapshot

Debio 4126 (Debio 4126) — Debiopharm International SA. Debio 4126 is a selective inhibitor of mitochondrial complex I that disrupts energy metabolism in cancer cells.

Comparator set (1 drugs)

Auto-detected by same drug class / molecular target / therapeutic area, ranked by phase + recency. Override with ?vs=slug1,slug2,….

Drug	Generic	Sponsor	Phase	Class	Target	Approval / PDUFA
Debio 4126 TARGET	Debio 4126	Debiopharm International SA	phase 3	Mitochondrial complex I inhibitor	Mitochondrial complex I (NADH dehydrogenase)
Debio 4326	Debio 4326	Debiopharm International SA	phase 3	Mitochondrial complex I inhibitor	Mitochondrial complex I (NADH dehydrogenase)

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this set.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this set.

Patent timeline (forward window)

No upcoming patent expiries for this set.

Sponsor landscape (Mitochondrial complex I inhibitor class)

Debiopharm International SA · 2 drugs in this class

Subscribe to ongoing alerts

Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:

Cite this brief

Drug Landscape (2026). Debio 4126 — Competitive Intelligence Brief. https://druglandscape.com/ci/debio-4126. Accessed 2026-05-15.

Build your own brief

Pick any drug + add comparators:

https://druglandscape.com/ci/{slug} — auto-detected competitors
https://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3 — explicit comparators
Brand names auto-resolve: /ci/keytruda → 301 → /ci/pembrolizumab